Charles River Laboratories International (CRL) Capital Expenditures Growth (3y) (2012 - 2025)
Charles River Laboratories International (CRL) Capital Expenditures Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -6.36% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -3.77% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -12.74% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 24.83% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 10.06% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -8.17% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -9.93% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -9.11% |
| 10 | Charles River Laboratories International | 11.36 Bn | 11.15 Bn | 744.94 Mn | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -0.03% |
| Sep 27, 2025 | -21.08% |
| Jun 28, 2025 | -24.75% |
| Mar 29, 2025 | -9.66% |
| Dec 28, 2024 | -8.52% |
| Sep 28, 2024 | -11.33% |
| Jun 29, 2024 | -5.26% |
| Mar 30, 2024 | 41.34% |
| Dec 30, 2023 | -3.76% |
| Sep 30, 2023 | 36.05% |
| Jul 1, 2023 | 35.98% |
| Apr 1, 2023 | 60.77% |
| Dec 31, 2022 | 53.43% |
| Sep 24, 2022 | 27.21% |
| Jun 25, 2022 | 49.53% |
| Mar 26, 2022 | 68.80% |
| Dec 25, 2021 | 56.84% |
| Sep 25, 2021 | 35.27% |
| Jun 26, 2021 | 29.84% |
| Mar 27, 2021 | 0.36% |